Fox Business - The Power to Prosper
Search Site

Mylan

White House calls for ‘economic patriotism’

FBN’s Lou Dobbs on Obama Administration efforts to discourage U.S. businesses from relocating their headquarters overseas.

Read More

  1. Actavis to buy Forest Labs in $25 billion deal

    Generic drugmaker Actavis Plc said it would acquire specialty pharmaceuticals company Forest Laboratories Inc in a cash and stock deal it valued at about $25 billion...

  2. Wheels Fly Off GM's CEO Pay Story

    Has General Motors' (NYSE:GM) new narrative on chief executive Mary Barra's compensation hit the wall faster than a crash-test dummy?FOX Business has reported as it ...

  3. Mylan Knocked To Equal-weight By Morgan Stanley

    Shares of Mylan Inc. were lowered to equal-weight from overweight on Monday by analysts at Morgan Stanley. While the pharmaceutical company's long-term growth is lik...

  4. Lilly defends blockbuster Alimta with unusual ammo

    Eli Lilly and Co, now facing one of the worst patent cliffs in its history, could find $15 billion in sorely needed relief if it beats the odds and wins a closely wa...

  5. Perrigo to Buy Ireland's Elan

    U.S. generic drugmaker Perrigo agreed to buy fellow drug company Elan for $8.6 billion on Monday in a deal that will hand it royalty rights from a blockbuster treatm...

  6. Actavis to Buy Warner Chilcott for $5 Billion in Stock

    Drug maker Actavis Inc. (ACT) agreed to acquire Warner Chilcott PLC (WCRX) for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specia...

  7. Actavis to Buy Warner Chilcott For $5 Billion in Stock

    Drug maker Actavis Inc. (ACT) agreed to acquire Warner Chilcott PLC (WCRX) for about $5 billion in an all-stock deal aimed at enlarging Actavis's portfolio of specia...

  8. Novartis Considers Possible Bid for Actavis

    A heated takeover battle has erupted around generic-drug company Actavis Inc. (ACT) as industry players seek to shore themselves up amid increasing competition and f...

  9. Valeant to Launch Own Version of Generic Zovirax in Response to Mylan's

    Valeant Pharmaceuticals International Inc. (VRX, VRX.T) said it will launch a generic version of its Zovirax ointment Thursday after Mylan Inc. (MYL) received approv...

  10. Pfizer Gets Reissued Celebrex Patent, Extends Exclusivity

    Pfizer Inc. (PFE) could gain an additional 18 months of U.S. exclusivity--and monopoly sales--for its blockbuster painkiller Celebrex because the government effectiv...

  11. Pfizer Get Reissued Patent for Celebrex

    Pfizer Inc. (PFE) said the U.S. Patent & Trademark Office reissued a patent on the active ingredient in Celebrex, extending the painkiller's exclusivity to 2015 from...

  12. Market Wrap for Thursday, February 28: Stocks close Little Changed

    The stock market was little changed on Thursday as investors evaluated mixed economic reports.Jobless claims data and Chicago PMI was positive, but a second Q4 GDP e...

  1. $7B shakedown for Citigroup?

    Money Map Press’ Keith Fitz-Gerald, FOX News contributor Guy Benson and FBN’s Nicole Petallides on the markets, Shire, AbbVie, corporate taxes, gold, oil and Citigroup’s settlement with the DOJ.

  2. Market correction coming?

    S&P Capital IQ chief equity strategist Sam Stovall and Wells Fargo Securities senior equity strategist Gina Martin Adams on whether 2014 will be a year of consolidation.

  3. Nasdaq Turns Solidly Higher in Volatile Action

    FOX Business: Capitalism Lives HereThe embattled Nasdaq swung solidly into positive territory in choppy action on Tuesday as traders scooped up beaten-down stocks.To...

  4. Equity Futures Higher Ahead of Monthly Jobs Report

    Stock index futures advanced modestly on Friday, putting the S&P 500 on track to hold near its record high, ahead of the monthly payrolls report.The employment repor...

  5. Mylan May Buy Swedish Pharma Group Meda: WSJ

    Generic drug group Mylan Inc. is mulling the purchase of Swedish pharmaceutical group Meda AB , The Wall Street Journal reported on Friday, citing persons close to t...

  6. Pfizer Loses Ruling On Celebrex Patent Dispute

    Pfizer Inc. on Wednesday announced it lost a patent ruling for its top-selling arthritis drug Celebrex, as the Eastern District Court of Virginia invalidated what is...

  7. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    Shares of Pfizer (NYSE:PFE) fell 1% Wednesday after a U.S. federal court invalidated the reissue patent for its blockbuster osteoarthritis drug Celebrex that would h...

‹ Prev123Next ›
Freebase CC-BY
Source: Mylan on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL